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We investigated the association of polymorphisms in CCR5,
the major human immunodeficiency virus (HIV)–1 cor-
eceptor, and copy number of its potent ligand CCL3L1 with
tuberculosis in 298 individuals from Colombia. The CCR5-
HHD haplotype, a known genetic determinant of increased
susceptibility to HIV-AIDS, and a high copy number of
CCL3L1, a known genetic determinant of enhanced CCL3/
CCL3L1 chemokine expression, each associated with pres-
ence of tuberculosis. Furthermore, CCR5-HHD was associ-
ated with higher CCR5 gene and surface expression. These
results substantiate the strong link between the pro-
inflammatory effects of CCR5 and its ligands with active
tuberculosis and suggest that chemokine-chemokine re-
ceptor genetic determinants may influence tuberculosis in
addition to HIV/AIDS.
Tuberculosis (TB) is still widespread, and according to the World
Health Organization, 2 billion people are infected with the caus-
ative bacillus Mycobacterium tuberculosis [1]. Although 10% of
infected persons develop active TB, the precise basis by which the
majority of infected persons never experience progression to active
TB remains unknown [1]. In addition to the environment and
bacterium, host genetic differences that influence the in-
flammatory response are thought to contribute significantly to the
final outcome of infection [1].
Genes encoding chemokines and their cognate receptors play
a key role in the inflammatory response during TB. Prior studies
have shown that (1) CC chemokine receptor 5 (CCR5), the major
human immunodeficiency virus (HIV)–1 coreceptor, is highly
expressed on T helper (Th) 1 cells (discussed in [2]); (2) Th1
responses play a critical role in immunity against TB [3]; (3)
compared with healthy individuals, the levels of CCR5 are elevated
in Th cells in patients with pulmonary TB [3, 4]; (4) CCR5 ex-
pression is increased in humans and rhesus monkeys with active
TB [5, 6]; (5) the ligands of CCR5, such as CCL3 and CCL5, are
also increased during TB [3, 4, 6, 7]; and (6) cell-mediated im-
munity (CMI) is a central determinant of TB resistance [3], and
both CCR5 and CCL3L1, the most potent ligand of CCR5 [8],
influence CMI (discussed in [9]). However, the association of
variations in the chemokine-chemokine receptor pair CCL3L1
and CCR5 with TB in HIV-negative subjects is unknown. To-
gether, these observations prompted us to test the hypothesis that
variations in CCR5 and CCL3L1 gene copy number are associated
with TB susceptibility. We tested this hypothesis in individuals




We evaluated 114 patients with TB and 184 healthy control
subjects from the Paisa community in northwestern Colombia
(South America), where TB has moderately-high endemicity.
Additional characteristics of the study participants have been
described, (see [10] and Supplementary Methods). Historical
and genetic evidence suggest that this community is genetically
isolated, with a documented low degree of admixture and
a calculated ancestral ethnic composition of 85% white, 15%
Amerindian, and a non-significant African contribution (see
Supplementary Methods).
Genotyping
The methods for genotyping the CCR5 polymorphisms that
allow for generation of the 9 major CCR5 haplotypes are as
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described elsewhere [8, 11, 12]. CCL3L1 gene copy number was
determined as described elsewhere [8]. We genotyped a vali-
dated set of 96 ancestry informative markers (AIMs) using
TaqMan genotyping assays (see Supplementary Methods).
Reporter Assays and CCR5 Expression
We introduced promoter sequences specific to HHA, HHB, and
HHD CCR5 haplotypes into a firefly luciferase reporter vector
and then evaluated the transcriptional strength of these haplo-
type-specific reporter constructs in in vitro transcription assays
using methods described elsewhere [12] and in the Supple-
mentary Methods section. Transcriptional activity was assessed
in a Jurkat T-cell line and in anti-CD3/CD28 activated periph-
eral blood mononuclear cells (PBMCs) from healthy persons
(see Supplementary Methods). CCR5 levels on CD41 T cells
were assessed by fluorescence activated cell sorting (see Sup-
plementary Methods).
Statistical Analysis
The association of CCR5 haplotypes or CCL3L1 gene copy
number with the risk of TB was evaluated using multiple logistic
regression analyses. On the basis of the mean CCL3L1 copy
number found in the control group (which was 2), we stratified
the study subjects into 3 groups: those with ,2, 2, or .2
CCL3L1 copies. We examined the potential contribution of
population admixture to genotype-phenotype associations
by using 96 AIMs with the EIGENSTRAT method and
STRUCTURE software (see Supplementary Methods).
RESULTS
On the basis of linkage disequilibrium patterns, the major
polymorphisms in CCR2-CCR5 were categorized into 9 CCR5
haplotypes, as described elsewhere ([12]; Figure 1A). We found
that all of the polymorphisms typed were in Hardy-Weinberg
equilibrium in control subjects. The CCR5-HHC haplotype was
the most common haplotype in both case patients and control
subjects, followed by HHE and HHF*2 (Figure 1B). In control
subjects, 2 copies of CCL3L1 was the median gene copy number,
whereas in case patients 2 and 3 CCL3L1 copies were the most
frequent values (Figure 1C).
The proportion of men was higher among case patients (5 50
patients [56.82%]) than among control subjects ( 5 38 patients
[43.18%]). The mean patient age (6 standard deviation) was
39.83 6 16.17 years, whereas the mean age (6 standard de-
viation) of the control subjects was 46.416 16.04 years. Younger
age (odds ratio [OR],5 0.98; 95% confidence interval [CI,]5 ,
0.97–0.99; P5 .003) and male sex (OR,5 3.08; 95%CI,5 1.82–
5.22; P , .001) was significantly associated with presence of
TB. We therefore included these 2 variables along with the
CCR5 haplotypes and a copy number of CCL3L1 that was less
than or greater than 2 copies in a single multiple logistic re-
gression model, to determine whether variations in CCR5 and
CCL3L1 were independently associated with TB. In the full
model, CCR5-HHD (OR, 5 4.32; 95% CI, 5 1.27–14.7; P 5
.019) and possession of .2 CCL3L1 copies (OR, 5 1.84; 95%
CI,5 1.02–3.31; P5 .043) were significantly and independently
associated with the presence of TB (Table 1, full model).
In the final step-wise regression model, we found that, in-
dependent of age and sex, CCR5-HHD haplotype (OR, 5 3.95;
95% CI,5 1.28–12.18; P5 .017) and possession of.2 CCL3L1
copies (OR, 5 1.75; 95% CI, 5 1.04–2.92; P 5 .034) were
significantly associated with the presence of TB (Table 1, final
model). Concordant results were obtained when we analyzed
only those control subjects (n 5 85) who had a tuberculin re-
action of >10 mm (data not shown).
Because the CCR5-HHD haplotype is commonly found in
persons of African ancestry but is also present in individuals of
European and Hispanic ancestry [11], we examined whether the
associations observed for this haplotype were because of potential
population admixture. However, we found that genetic stratifi-
cation was an unlikely explanation for the observed association of
CCR5-HHD with risk of TB (Supplementary Figure 1). Collec-
tively, these observations suggested that both the CCR5-HHD
haplotype and a high CCL3L1 gene copy number were strongly
associated with the presence of TB in the study population.
A high CCL3L1 gene copy number is a genetic determinant of
increased CCL3/CCL3L1 expression [8], and this may provide
a possible functional basis by which this chemokine genotype
affects TB pathogenesis. It is unknown whether the single nucle-
otide polymorphism (SNP) at 22132T that distinguishes the
CCR5-HHD haplotype from all other haplotypes (Figure 1A) has
an impact on gene expression. To evaluate this, we considered the
following framework. CCR5-HHA haplotype is the ancestral
haplotype, and CCR5 haplotypes can be broadly dichotomized
into those containing 22459G/22135T (HH-A, -B, -C, and -D)
versus 22459A/22135C (HH-E, -F, and -G) (Figure 1A) [12].
We demonstrated previously that, compared with the promoter
sequences of 22459A/22135C-containing haplotypes (HHE,
HHF, or HHG), the HHA promoter sequence exhibited the least
transcriptional activity [12]. Because 22459G/22135T is com-
mon to HHA, HHB, HHC, and HHD haplotypes (Figure 1A),
one possibility was that the promoters of these 4 haplotypes have
similar transcriptional strengths. An alternative possibility was
that the combinatorial content of promoter SNPs that differen-
tiate HHB, HHC, and HHD from the ancestral HHA (Figure 1A)
uniquely affects gene expression.
We found previously that, in the K562 cell line, HHA- and
HHC-specific promoter sequences had similarly low transcrip-
tional activity [12]. Here, we found that, in the Jurkat T-cell line,
CCR5-HHB and CCR5-HHD promoter sequences had higher
transcriptional activity than did HHA (Figure 1D). We con-
ducted similar transcriptional analyses in primary PBMCs ob-
tained from healthy persons. These analyses revealed that
although there was some donor-to-donor variability, promoter











Figure 1. Distribution of CCR5/CCL3L1 genotypes and influence of CCR5 promoter polymorphisms on gene and surface expression. A, Schematic
represents the evolutionary relationship among CCR5 human haplogroups (HH) that contain the major CCR5 haplotypes designated as HH-A, -B, -C, -D, -E,
F*1, F*2, G*1, and G*2 [12]. Haplotype classification is based on the linkage disequilibrium of the indicated 9 polymorphisms in CCR2 (V64I), CCR5
promoter 1 (Pr1), and the CCR5 open reading frame (ORF; D32) [12]. CCR5-HHA is the ancestral haplotype based on the evolutionary conservation at the
indicated nucleotide positions with the chimpanzee CCR5 [12]. Nucleotide numbering is according to Mummidi et al [12]. The signature single-nucleotide
polymorphisms (SNPs) that distinguish CCR5 haplotypes from the ancestral haplotype are in boldface font. The haplotypes studied in this report are
highlighted in colored boxes and are color-matched. B and C, Distribution of CCR5 haplotypes (B) and CCL3L1 gene copy number (C) in case patients (n5
114) and control subjects (n 5 184). D, Box-whisker plot showing haplotype-specific differences in CCR5 gene transcriptional activity in Jurkat T cells.
Cells were cotransfected with HHA-, HHB-, and HHD-specific firefly luciferase reporter constructs and Renilla luciferase construct, and dual luciferase
assays were performed. Data shown are from 4 independent experiments, and the transcriptional activity was log-transformed after normalization to
HHA (see Supplementary Methods). Significance values shown at the top for the indicated comparisons were obtained using the Mann-Whitney U test. E,
Haplotype-specific differences in CCR5 transcriptional activity in peripheral blood mononuclear cells (PBMCs). Haplotype-specific HHA (green), HHB
(blue), and HHC (red) promoter constructs were nucleofected into PBMCs stimulated with anti-CD3/CD28 antibodies and transcriptional activity was
assessed. All data were normalized to the transcriptional activity of the HHA-containing reporter vector. F, CCR5 surface expression on CD41HLA-DR1
cells in a cohort of 90 human immunodeficiency virus–uninfected sex workers from South Africa. CCR5 expression was log-transformed. The height of the
bar indicates the mean CCR5 surface expression in subjects who possess (1) or lack (-) the CCR5-HHD haplotype, and the error bars indicate the standard
error of the mean. The P values were calculated using the Student t-test.











sequences of HHB—and especially those of HHD—had higher
transcriptional activity than did those of HHA in anti-CD3/
CD28 activated PBMCs (Figure 1E). To assess whether the
higher gene expression associated with CCR5-HHD translates to
increased protein expression, we evaluated a cohort of 90 black,
HIV-negative female sex workers from South Africa who were
part of the CAPRISA 002 acute infection study (see Supple-
mentary Methods). In these women, compared with women
who lacked HHD, those possessing CCR5-HHD had higher
CCR5 expression on CD41HLA-DR1 T cells (Figure 1F). Of
note, although CCR5-HHB is rare, like CCR5-HHD, it is also
more prevalent among persons of African ancestry [11] and
consistent with the results of our transcriptional studies, the 2
women who had HHB-containing genotypes also had high
CCR5 surface expression (data not shown).
In previous studies, we demonstrated that the G/T trans-
version at position22554 (common to HHB, HHC, and HHD)
associates with differences in binding of the NF-jB family of
transcription factors [12]. Here, we found that nuclear factors
from Jurkat T cells bound differentially to22132T and22132C
alleles (Supplementary Figure 2). Although bioinformatic anal-
yses suggested the binding of FOXO family transcription factors
to the cis-regions in the close vicinity of HHD-specific SNP at
22132, competition electrophoretic mobility shift assays with
oligonucleotides containing FOXO consensus sequences were
not conclusive (Supplementary Figure 2).
DISCUSSION
We found that the CCR5-HHD haplotype and a copy number of
CCL3L1 that is greater than the average found in a northwestern
Colombian population was associated with a greater likelihood of
active TB. These results support our hypothesis that CCR5 and its
potent ligand CCL3L1 may contribute to TB pathogenesis.
The primary host immune response, which includes chemo-
kine-dependent leukocyte recruitment and consequent granu-
loma formation, favors the host by providing local control of
mycobacterial spread. The precise factors that tilt the balance
from contained infection to active TB are unknown. However,
there is increasing recognition that TB is an immunopatholog-
ical disease, in which active TB develops due to uncontrolled
host inflammatory responses to the pathogen (discussed in [7]).
Thus, the concept was advanced that among immunocompe-
tent hosts, the outcome of TB is a result of quantitatively and
genetically controlled differences in the magnitude of the in-
flammatory responses, rather than a direct consequence of
mycobacterial colonization [7]. This is in accord with bur-
geoning data suggesting a critical role of the proinflammatory
effects of chemokines and their receptors in TB pathogenesis,
including CCR5 and its ligands. Notably, the CCR5 ligand–
CCR5 receptor axis plays a key role in amplifying immune re-
sponses (discussed in [2]).
The gene encoding CCL3L1 is subject to gene copy number
variation (range, 0–12), with higher copies in persons of African
ancestry [8]. Because CCL3L1 copy number is associated with
increased CCL3/CCL3L chemokine production [8], it is con-
ceivable that a high copy number may associate with proin-
flammatory state that leads to enhanced immunopathology that
favors development of active TB. This possibility is underscored
by the observation that increased CCL3 levels favor TB pro-
gression [7] and that the pro-inflammatory effects of CCL3 may
contribute to tissue inflammation independently of M. tuber-
culosis load [6, 7]. Conceivably, in the context of persons con-
current HIV infection and TB, the protective HIV-suppressive
effects of high CCL3L1 chemokine expression may be offset by
its pro-inflammatory effects on TB.
Our reporter gene studies indicate that the combinatorial
SNP makeup of the CCR5-HHD haplotype is associated with
enhanced CCR5 gene expression in activated PBMCs. As a cor-
ollary, CCR5-HHD is also associated with higher surface ex-
pression on activated (HLA-DR1) CD41 T cells. Together,
these findings provide a possible functional basis for the ob-
served association of CCR5-HHD with active TB and un-
derscore the importance of accounting for the combinatorial
content of SNPs in the CCR5 promoter haplotypes when eval-
uating their impact on gene/surface expression.
Interestingly, CCR5 HHD-containing genotypes have also
been associated with adverse outcomes in HIV/AIDS, a clinical
setting in which higher levels of CCR5 are a strong correlate of
Table 1. Association of CCR5 Haplotypes and CCL3L1 Gene Copy
Number With Tuberculosis
Full model, OR (95% CI)
CCR5/CCL3L1
Unadjusted Adjusteda
OR (95% CI) P OR 95% CI P
CCR5 HHA 1.01 (0.42–2.40) .985 1.28 (0.52–3.15) .591
CCR5 HHC 1.17 (0.57–2.41) .666 1.26 (0.59–2.70) .555
CCR5 HHD 4.13 (1.27 - 13.5) .019 4.32 (1.27 - 14.7) .019
CCR5 HHE 0.70 (0.36–1.37) .299 0.78 (0.38–1.59) .493
CCR5 HHF*1 1.24 (0.36–4.22) .732 1.13 (0.30–4.20) .860
CCR5 HHF*2 0.90 (0.44–1.86) .778 1.04 (0.48–2.25) .919
CCR5 HHG*1 1.21 (0.55–2.67) .632 1.44 (0.62–3.33) .399
CCR5 HHG*2 0.81 (0.13–4.89) .815 1.04 (0.14–7.63) .965
CCL3L1 ,2 copies 1.04 (0.46–2.32) .931 1.18 (0.51–2.76) .695
CCL3L1 >2 copies 1.94 (1.11 – 3.38) .019 1.84 (1.02 – 3.31) .043
Final Modelb
CCR5/CCL3L1
CCR5 HHD 4.15 (1.42 -12.13) .009 3.95 (1.28 -12.18) .017
CCL3L1 >2 copies 1.95 (1.19 – 3.17) .007 1.75 (1.04 – 2.92) .034
NOTE. Boldface type indicates statistical significance. CI, confidence
interval; OR, odds ratio.
a Adjusted for age and sex.
b The results for the final model are from step-wise multiple logistic
regression analysis with a retention criterion of .1.











increased susceptibility to HIV infections and AIDS. Of note, we
and others have shown that compared with those genotypes that
do not contain HHD, CCR5 HHD-containing genotypes are
associated with an increased risk of acquiring HIV infection [13,
14], having higher plasma viral loads [15], experiencing a sig-
nificant increase in vaginal shedding of HIV-1–infected cells
[16], and having faster rates of progression to AIDS and death
[11, 16]. Thus, it is possible that CCR5-HHD haplotype may
serve as a common genetic factor for both HIV infection and TB.
Intriguingly, the CCR5-HHD haplotype is found more com-
monly in persons of African ancestry, and whether its dual in-
fluence on HIV infection and TB susceptibility contributes to
the growing burden of concurrent HIV infection and TB
in Africa requires further evaluation. Taken together, the results
of our association studies substantiate the accumulating
data suggesting a strong role for CCR5 and its ligands in TB
pathogenesis.
Supplementary Data
Supplementary methods and figures are available at http://
jid.oxfordjournals.org/ online.
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